Nuclear Medicine: Page 21

Novartis restarts supply of Lutathera and Pluvicto

By AuntMinnie.com staff writers

Novartis has taken steps to resolve quality issues that halted production of its Lu-177 DOTATATE (Lutathera) and Lu-177-PSMA-617 (Pluvicto) radiopharmaceutical cancer therapies, yet the dip in supply is still affecting patients, their families, and care teams.

June 30, 2022

Fuzionaire, McMaster ink collaboration agreement on theranostics

By AuntMinnie.com staff writers

Fuzionaire Diagnostics and McMaster University in Hamilton, Ontario, Canada, have signed a collaborative research agreement to develop theranostic radiopharmaceuticals.

June 28, 2022

Bayer inks deal to buy Ac-225 from BWXT Medical

By AuntMinnie.com staff writers

Bayer has signed a deal to buy the radioisotope actinium-225 (Ac-225) at predetermined prices from BWXT Medical, a subsidiary of BWX Technologies.

June 26, 2022

ARRT wins judgment in RT credentialing case

By AuntMinnie.com staff writers

The American Registry of Radiologic Technologists (ARRT) has won a court decision against a radiologic technologist (RT) who allegedly falsified having ARRT credentials.

June 20, 2022

Bruce Power sends first shipment of lutetium-177 to Munich

By AuntMinnie.com staff writers

Canada's Bruce Power has produced its first shipment of the radioisotope lutetium-177 at its nuclear power reactor in Bruce County, Ontario.

June 20, 2022

NorthStar names Scholz as new president and COO

By AuntMinnie.com staff writers

NorthStar Medical Radioisotopes has promoted Frank Scholz, PhD, to president and chief operating officer (COO).

June 20, 2022

Can PET/MRI correlate tau with first responders' cognitive issues?

By Wayne Forrest

PET/MR images of tau deposits among emergency responders on 9/11 are concerning, but they fall short of a definitive link to dementia, according to research presented at the Society of Nuclear Medicine and Molecular Imaging's annual meeting in Vancouver, Canada.

June 20, 2022

BWXT Medical, TRIUMF ink medical isotope production deal

By AuntMinnie.com staff writers

BWXT Medical and Canada's particle accelerator center TRIUMF have executed a licensing and services agreement that will expand their existing medical isotope production partnership.

June 13, 2022

FES-PET/CT can help detect breast cancer

By Wayne Forrest

F-18 fluoroestradiol (FES)-PET/CT can be useful in detecting clinically significant breast cancer, according to preliminary study results presented June 12 at the Society of Nuclear Medicine and Molecular Imaging annual meeting in Vancouver, Canada.

June 13, 2022

Do nuclear medicine physicians need a new identity?

By Will Morton

VANCOUVER, BC - It's time to embrace a new identity in nuclear medicine -- namely, that of the "nuclear oncologist," said Dr. Richard Wahl in the president's address June 12 at the Society of Nuclear Medicine and Molecular Imaging annual meeting.

June 12, 2022

SNMMI releases slate of officers for 2022-2023 term

By AuntMinnie.com staff writers

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released its slate of officers for its 2022-2023 term, headed by Dr. Munir Ghesani as president.

June 12, 2022

Siemens showcases new SPECT/CT scanner at SNMMI

By AuntMinnie.com staff writers

Siemens Healthineers unveiled its new Symbia Pro.specta SPECT/CT Scanner and announced its market clearance in the U.S. and Europe June 12 at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting in Vancouver, Canada.

June 12, 2022

Previous Page

Page 21 of 439

Next Page